US and UK Reach Zero Tariffs Agreement on Pharmaceuticals
The UK and US have reached a deal to keep tariffs on UK pharmaceutical exports to the US at zero for three years, while the UK will increase NHS drug spending and adjust pricing thresholds, aiming to boost trade, investment, and the UK’s position in global life sciences, amidst ongoing tensions over drug costs and investments.